VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

live attenuated Brucella abortus per mutant vaccine
Vaccine Information
  • Vaccine Name: live attenuated Brucella abortus per mutant vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009154
  • Type: Live attenuated vaccine
  • Status: Research
  • Host Species for Licensed Use: Cattle
  • Host Species as Laboratory Animal Model: Mus musculus
  • Antigen: per gene mutant (perosamine synthetase)
  • Preparation: Live attenuated rough lipopolysaccharide mutant with per gene disruption. (Monreal et al, 2003)
  • Description: The per mutant was evaluated as a rough vaccine candidate in mice. Efficacy: Induced protection against Brucella abortus but less than the standard smooth vaccine strain 19; afforded similar protection to strain 19 against Brucella ovis. Immune response: Induced antibodies to rough LPS and outer membrane proteins; protection attributed largely to anti O-polysaccharide antibodies. (Monreal et al, 2003)
Host Response

Mouse Response

  • Immune Response: Induced antibodies to rough LPS and outer membrane proteins; protection attributed largely to anti O-polysaccharide antibodies. (Monreal et al, 2003)
  • Challenge Protocol: Mouse model challenge experiments. (Monreal et al, 2003)
  • Efficacy: Induced protection against Brucella abortus but less than the standard smooth vaccine strain 19; afforded similar protection to strain 19 against Brucella ovis. (Monreal et al, 2003)
  • Description: Mouse model challenge experiments. (Monreal et al, 2003)
References
Monreal et al, 2003: Monreal D, Grilló MJ, González D, Marín CM, De Miguel MJ, López-Goñi I, Blasco JM, Cloeckaert A, Moriyón I. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infection and immunity. 2003 Jun; 71(6); 3261-71. [PubMed: 12761107].